Dr. Agarwal's Health Care has completed an inter-se transfer of shares between promoter group members, with official regulatory documentation filed on March 23, 2026. Dr. Athiya Agarwal acquired 14,41,568 shares representing 0.455% of the company's total share capital through a gift transaction from Dr. Anosh Agarwal, executed on March 19, 2026.

Official Regulatory Filing

The transaction was formally disclosed through a comprehensive letter dated March 23, 2026, addressed to BSE Limited, National Stock Exchange of India Limited, and the company's compliance officer. The disclosure was made under Regulation 29(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Shareholding Changes

The regulatory filing provides detailed shareholding information showing Dr. Athiya Agarwal's position before and after the acquisition. Prior to the transaction, Dr. Athiya Agarwal held 1,26,61,975 shares representing 4.00% of the total share capital.

Company Structure and Compliance

Dr. Agarwal's Health Care Limited maintains its equity share capital at 31,68,07,506 equity shares of Re. 1/- each, aggregating to ₹31,68,07,506. The company's shares are listed on both National Stock Exchange of India Limited and BSE Limited.

Transaction Characteristics

The share transfer was executed as an inter-se transfer between promoter group members by way of gift among immediate relatives. Both transferor and transferee belong to the promoter/promoter group category, with no monetary consideration involved in the transaction. The transfer was completed through off-market mechanism while maintaining full regulatory compliance with SEBI requirements.

Dr. Agarwal's Health Care Limited has filed prior intimation with stock exchanges regarding a proposed inter-se share transfer within its promoter group, scheduled for March 13, 2026. The transaction involves the transfer of 14,41,568 shares between immediate relatives within the promoter family.

Transaction Details

The proposed share transfer will see Dr. Athiya Agarwal acquire shares from Dr. Anosh Agarwal through a gift arrangement between immediate relatives. The transaction parameters are outlined below:

Shareholding Impact

The inter-se transfer will result in changes to individual shareholdings within the promoter group while maintaining the overall promoter group stake. The shareholding pattern before and after the transaction shows:

Regulatory Compliance

The transaction is being conducted under Regulation 10(1)(a)(i) of SEBI SAST Regulations, 2011, which provides exemption for inter-se transfers among immediate relatives. Key compliance aspects include:

• Prior intimation filed under Regulation 10(5) of SEBI SAST Regulations
• Transfer qualifies for open offer exemption as inter-se transfer between immediate relatives
• No change in total promoter group shareholding
• Declaration of compliance with applicable disclosure requirements

Strategic Rationale

According to the filing, the proposed acquisition represents a private family arrangement among immediate relatives aimed at streamlining the family's assets and business interests. The transaction involves no monetary consideration as it is structured as a gift between family members.

The company has submitted the required declarations confirming compliance with all conditions specified under regulation 10(1)(a) regarding exemptions and applicable disclosure requirements under Chapter V of the Takeover Regulations, 2011.